Citicoline for newborns with birth oxygen loss
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a medicine called citicoline can help newborns who had a brief lack of oxygen around birth, which can affect their brain. It aims to see if the medicine improves their recovery and brain blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newborns who had signs of low oxygen at birth (APGAR score below 8 at 5 minutes)
- For babies born at another hospital, admitted within the last 24 hours with signs of oxygen loss during birth
- Must be born at or after 35 weeks of pregnancy
- Must not have received therapeutic hypothermia (a cooling treatment)
- Parents must agree to allow their baby to participate
- No known birth defects or genetic conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if citicoline, a brain-protecting supplement, can help newborns with moderate to severe brain injury from lack of oxygen. It is for babies who have not gotten cooling treatment.
This trial studies whether a medicine called citicoline can protect the brain in newborns who had low oxygen (hypoxia). It may help reduce brain injury in babies, but it does not include babies with a specific severe brain condition.
This trial tests if giving caffeine to newborns who had low oxygen at birth can help protect their brains. It compares caffeine plus standard care to placebo plus standard care for moderate to severe hypoxic ischemic encephalopathy (HIE).
This trial is testing a treatment for newborns who had low oxygen around birth, leading to brain injury. It may help babies who did not get certain medicines before birth.
This trial studies outcomes in newborns who had breathing problems from low oxygen before or during birth and were treated with a cooling therapy (therapeutic hypothermia). It may help doctors understand which babies benefit most and what recovery looks like over time.
This Phase 3 study tests whether citicoline can act as a protective treatment for the brain in babies born early and needing breathing support. It may help reduce risks tied to prematurity and breathing complications by supporting the brain’s health.
Hear when a new Hypoxic Ischaemic Encephalopathy (HIE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.